Impinj v. NXP: RFID Patent Dispute Ends in Settlement

📄 View Full Report 📥 Export PDF 🔗 Share ⭐ Save

In one of the more closely watched RFID patent infringement battles in recent memory, Impinj, Inc. and NXP USA, Inc. resolved their multiyear dispute through a confidential settlement, resulting in a dismissal with prejudice before Chief Judge Alan D. Albright of the U.S. District Court for the Western District of Texas. Filed on May 25, 2021, and formally closed on March 13, 2024, Case No. 6:21-cv-00530 spanned nearly three years and placed nine Impinj patents directly against NXP’s flagship RAIN RFID and UHF Gen2 integrated circuit product lines.

For IP professionals tracking RFID patent litigation, this case carries significant weight. The breadth of the patent portfolio asserted—spanning endpoint IC architecture, memory management, and tag communication protocols—signals how aggressively patent holders in the RFID semiconductor space are willing to litigate foundational technology rights. The settlement outcome, while leaving no binding precedent, reflects the complex cost-benefit calculus that both plaintiffs and defendants face in high-stakes, multi-patent IC disputes.

📋 Case Summary

Case NameImpinj, Inc. v. NXP USA, Inc.
Case Number6:21-cv-00530 (W.D. Tex.)
CourtU.S. District Court for the Western District of Texas
DurationMay 2021 – Mar 2024 ~3 years
OutcomeSettlement – Dismissed with Prejudice
Patents at Issue
Accused ProductsNXP UCODE 7, UCODE 8, UCODE 9 ICs, UHF Gen2 RFID tag chips, RAIN RFID ICs

Case Overview

The Parties

⚖️ Plaintiff

Seattle-based semiconductor company, pioneer in RAIN RFID technology, known for its Monza line of endpoint ICs and extensive patent portfolio.

🛡️ Defendant

U.S. arm of global semiconductor leader NXP Semiconductors. Its UCODE product line competes in the UHF Gen2 RFID market.

The Patents at Issue

Impinj asserted nine U.S. patents spanning RFID endpoint IC technology. These patents collectively cover core aspects of RFID endpoint IC architecture, including tag memory management, signal processing, power harvesting, and communication protocol compliance under the EPC Gen2/RAIN RFID standard.

🔍

Developing RFID products?

Check if your RFID IC design might infringe these or related patents before launch.

Run FTO Check →

Accused Products

Impinj’s infringement allegations targeted NXP’s core RFID IC product portfolio, specifically:

  • UCODE 7, UCODE 8, and UCODE 9 ICs
  • UHF Gen2 RFID tag chips
  • RAIN RFID ICs generally, including endpoint integrated circuits

These products compete head-to-head with Impinj’s Monza R6 IC and M700 chips in the global RFID tag IC market—making the commercial stakes of this litigation exceptionally high for both parties.

Legal Representation

Plaintiff Impinj was represented by Perkins Coie LLP, with attorney Daniel T. Keese listed as lead counsel.

Defendants NXP was represented by Jones Day, with attorney David L. Witcoff as lead counsel.

Both firms are recognized as elite IP litigation practices, underscoring the seriousness with which each party approached this dispute.

Litigation Timeline & Procedural History

Impinj filed suit on May 25, 2021, in the Western District of Texas—a deliberate venue choice. Under Chief Judge Alan D. Albright, the Waco Division became one of the most plaintiff-favorable patent litigation venues in the United States, known for expedited scheduling, predictable claim construction procedures, and high trial rates relative to other districts. Judge Albright’s court drew significant national attention for its patent docket volume throughout 2020–2023, making it a strategic destination for patent assertion.

The case proceeded at the district court (first instance) level, with the dispute spanning approximately 32 months from filing to closure. The case was formally closed on March 13, 2024, following the parties’ joint stipulation of dismissal.

Specific intermediate milestones—including claim construction hearings, Markman orders, summary judgment motions, or inter partes review (IPR) petitions—were not disclosed in the available case record. However, the duration and complexity of a nine-patent assertion against a sophisticated defendant like NXP strongly suggests substantive procedural activity preceded the settlement.

The Verdict & Legal Analysis

Outcome

The case concluded via dismissal with prejudice pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(ii), following a private settlement agreement between the parties. All claims, counterclaims, and affirmative defenses were dismissed, with each party bearing its own costs and attorneys’ fees. No damages award or injunctive relief was entered by the court.

The specific financial terms of the settlement—including any licensing agreement, royalty structure, or lump-sum payment—were not publicly disclosed.

Counterclaim Structure

Notably, NXP USA filed counterclaims against Impinj, which were also resolved and dismissed under the settlement. While the nature of NXP’s counterclaims is not detailed in the available record, such counterclaims in patent cases typically include declarations of non-infringement, patent invalidity challenges, and potentially patent misuse or antitrust claims. The bilateral dismissal suggests both parties reached a commercially pragmatic resolution rather than a one-sided capitulation.

Legal Significance

From a claim construction perspective, this case presented complex interpretive challenges across nine patents with overlapping technology claims in the RFID IC space. Multi-patent assertions of this scale often require the court to construe dozens of claim terms across competing patent families—a resource-intensive process that frequently exposes plaintiffs to invalidity risk and defendants to infringement liability simultaneously.

The venue strategy itself carries legal significance. Impinj’s choice of the Western District of Texas under Judge Albright reflects a well-established plaintiff playbook during the 2021–2023 period. Subsequent Supreme Court and Federal Circuit guidance on venue transfer (see In re: Apple Inc., Fed. Cir. 2021) complicated this strategy for some cases, and any transfer motion practice in this proceeding would have been legally significant.

The dismissal with prejudice is consequential: neither party may relitigate the same claims on the same patents against the same products. This forecloses future assertion risk on the specific accused products but does not necessarily limit Impinj’s ability to assert the same patents against next-generation NXP products not covered by the settlement scope.

Strategic Takeaways

For Patent Holders: Impinj’s assertion of nine patents simultaneously reflects a portfolio depth strategy—asserting multiple patents reduces the defendant’s ability to design around any single claim while increasing settlement pressure. Patent holders in semiconductor spaces should consider building patent families that provide overlapping coverage of core IC functionalities.

For Accused Infringers: NXP’s counterclaim posture demonstrates the importance of mounting a robust invalidity defense, which creates settlement leverage even without reaching trial. Accused infringers should initiate Freedom to Operate (FTO) reviews for competitive IC product lines well before market launch to identify and mitigate potential exposure.

For R&D Teams: The accused products—UCODE 7, 8, and 9—represent mature, commercially deployed product lines. This case illustrates that legacy product architectures can carry litigation risk years after market introduction, particularly when competitors hold continuation patents that extend protection into more recent claim language.

Industry & Competitive Implications

The RFID semiconductor market is a multi-billion-dollar industry underpinning global supply chain digitization, retail inventory management, and IoT asset tracking. Impinj and NXP are the two dominant players in the UHF Gen2 RFID tag IC segment, making their patent dispute effectively a proxy battle for market control over the RAIN RFID ecosystem.

A confidential settlement of this nature—absent any public licensing terms—leaves market observers without clarity on whether NXP secured a cross-license, paid a royalty-bearing license, or negotiated product-specific carve-outs. Each outcome carries materially different competitive implications.

The case also reflects a broader licensing and settlement trend in semiconductor patent litigation: even well-resourced defendants like NXP frequently elect settlement over trial when facing multi-patent assertions from direct competitors, given the unpredictability of jury verdicts on technical patent claims.

Companies developing RFID endpoint ICs, particularly those entering the RAIN RFID market, should monitor Impinj’s patent portfolio activity—including continuation applications from the nine asserted patents—as potential future assertion risk vectors.

⚠️

Freedom to Operate (FTO) Analysis

This case highlights critical IP risks in RFID IC design. Choose your next step:

📋 Understand This Case’s Impact

Learn about the specific risks and implications from this litigation.

  • View all related patents in this technology space
  • See which companies are most active in RFID patents
  • Understand claim construction patterns from similar cases
📊 View Patent Landscape
⚠️
High Risk Area

UHF Gen2 RFID IC designs

📋
9 Patents at Issue

Core RFID endpoint IC technology

Proactive FTO

Essential for new product development

✅ Key Takeaways

For Patent Attorneys & Litigators

Multi-patent assertions in semiconductor cases create compounding settlement pressure; portfolio depth matters as much as individual claim strength.

Search related case law →

Western District of Texas under Judge Albright remained a strategically significant plaintiff venue through this case’s lifecycle.

Explore venue analytics →

Counterclaim strategies by defendants—even without trial—materially shape settlement dynamics.

Analyze counterclaim trends →

Dismissal with prejudice protects defendants from re-litigation on covered products but not necessarily future product generations.

Understand dismissal impacts →
For IP Professionals

Monitor Impinj’s RFID continuation patent filings as indicators of future assertion vectors in the RAIN RFID space.

Track patent family activity →

Settlement without disclosed terms leaves licensing norms in this technology area undefined—benchmark against publicly available RFID licensing rates.

Compare licensing rates →
🔒
Unlock R&D Team Recommendations
Get actionable RFID patent strategy steps for product teams, including FTO timing guidance and intellectual property lifecycle best practices.
Proactive FTO Guidance IP Due Diligence Global Patent Mapping
Explore Full Analysis in PatSnap Eureka

Frequently Asked Questions

Ready to Strengthen Your Patent Strategy?

Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.

PatSnap IP Intelligence Team

Patent Research & Competitive Intelligence · PatSnap

This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.

The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.

📊 2B+ Patent Data Points 🌍 120+ Countries Covered 🏢 18,000+ Customers Worldwide ⚖️ Global Litigation Database 🔍 Primary Source Verified

References

  1. USPTO Patent Full-Text Database – Search asserted patent numbers for claim-level analysis
  2. PACER Case Locator – Access full docket for Case No. 6:21-cv-00530 (W.D. Tex.)
  3. Federal Circuit RFID Patent Decisions – Track appellate precedents affecting RFID claim construction

This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.

⚖️ Disclaimer: This article is for informational purposes only and does not constitute legal advice. The analysis presented reflects publicly available case information and general legal principles. For specific advice regarding patent litigation, FTO analysis, or IP strategy, please consult a qualified patent attorney.